Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Drug Testing Equipment Market size was valued at USD 7.43 billion in 2024 and is likely to cross USD 29.54 billion by 2037, registering more than 11.2% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of drug testing equipment is estimated at USD 8.82 billion.
The growing usage of intoxicants and controlled substances and the rising misuse of prescribed medicines have emerged in the need to ascertain the level of intoxication in the body at any given point in time, which is elevating the market growth.
The increasing concern about the rising consumption of drugs by the young population which is leading to the mental crisis and surging crime rates in many countries of the world is thriving in the use of prevention tools such as drug testing. According to the National Center for Drug Abuse Statistics of 2023, youth drug abuse has now become a public health concern in America. In the year 2022, nearly 1-in-8 teenagers used prohibited drugs. Moreover, every year more than 1.16 million prisoners commit some drug-related offense and are arrested.
Drug Testing Equipment Sector: Growth Drivers and Challenges
Growth Drivers
-
Stringent Regulations of Sports Association – The adoption of several programs that are designed to detect the use of banned substances and strict drug testing for illegal drug abuse by athletes worldwide during the sports session is anticipated to propel the market growth. Sports organizations such as the International Olympic Committee (IOC), the International Sports Federation (ISF), and others have made drug testing mandatory for participants before participating in a sporting event.
-
Collaborations & Innovations in Testing Technology – The tangible benefits of collaborations include reduced medical errors, medication errors, and redundant tests, as well as innovative brainstorming, faster patient throughput, and improved provider satisfaction that come with a democratized and collegial care process. Intoximeters, Inc. with Abbott Healthcare Private Limited agreed to market SoToxa Mobile Test System of Abbott together with Alco-Sensor brand breath alcohol-testing products of Intoximeters. SoToxa is a handheld oral fluid testing solution that will be used to detect drug use.
-
Emerging Laws – As per the Biden-Harris Administration’s Unity Agenda, around USD 3.8 billion has been invested through the American Rescue Plan by the administration to address the mental health crisis and drug overdose plague in the United States.
Challenges
-
Emerging Policies & Ban on Testing of Drugs - Drug testing in some places (particularly the workplace) is regarded as a violation of employee privacy, which is expected to impede market growth. The drug consumption ban in certain areas, as well as accuracy issues, are expected to pose challenges to the drug screening market.
-
Lack of Accuracy in Many Cases
-
Slower Penetration Due to Privacy Concerns
Drug Testing Equipment Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
11.2% |
|
Base Year Market Size (2024) |
USD 7.43 billion |
|
Forecast Year Market Size (2037) |
USD 29.54 billion |
|
Regional Scope |
|
Drug Testing Equipment Segmentation
Sample (Blood, Urine, Oral Fluids, Breath, Hair)
The urine segment in the drug testing equipment market is expected to garner the largest revenue share of 35% by the year 2037 due to the growing use and trade of illegal and banned drugs such as opioids. Urine drug tests are majorly used to detect the positivity of substance abuse which is a cost-effective and non-invasive method that aids in the rapid detection of drug intake.
Moreover, the hair segment is further foreseen to witness to bring in notable revenue owing to its rapid adoption as is the least invasive method and this testing provides an extended detection window of about 90 days.
End User (Personal Users, Hospitals, Workplace & Schools, Criminal Justice Systems and Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, and Pain Management Centers)
Drug testing equipment market from the workplace & school segment will hold a significant growth rate in the upcoming years. With the changing organizational policies and the growing percentage of jobs requiring background verification for accessing workplace employment eligibility, the adoption of pre-employment drug tests is increasing. This will lead the segment to rise.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
Sample |
|
|
End User |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Global Drug Testing Equipment Industry - Regional Synopsis
North American Market Forecast
North America industry is anticipated to account for largest revenue share of 40% by 2037, The existence of giant players in the industry encouraging drug screening in the region with the increasing concern of augmenting drug abuse in countries such as the United States and the growing implementation of strict norms to vigorously tackle the drug problem. As per recent data from 2023, Americans constitute 12% of global drug users.
APAC Market Statistics
The Asia Pacific drug testing equipment market is estimated to register a growth rate of 21% through 2036. The growing use of substance abuse in the region and the rising prevalence of drug trafficking and the adoption of concealment methods and cross-border operations in South-East Asia specifically in Myanmar, Thailand, and Vietnam is leading to the stringent regulatory frameworks which is resulting in the expansion of drug testing equipment demand.
Companies Dominating the Drug Testing Equipment Landscape
- Sandoz International GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Quest Diagnostics Incorporated
- Butterfly Network, Inc.
- F. Hoffmann-La Roche
- Thermo Fisher Scientific, Inc.
- Siemens AG
- Bio-Rad Laboratories, Inc.
- Cordant Health Solutions
- Legacy Medical Services, LLC
- Omega Laboratories, Inc.
- GE Healthcare
Recent Developments
- Sandoz International GmbH announced the acquisition of the cephalosporin antibiotics business of GSK, to expand its portfolio in manufacturing drugs and medicines.
- Quest Diagnostics Incorporated partnered with Select Health of South Carolina Inc. to expand the lateral’s laboratory network for its dual eligible enrollees of Medicaid and Medicare-Medicaid.
- Butterfly Network, Inc. launched an augmented-reality capability to remotely guide Butterfly iQ ultrasound scanners.
- Report ID: 3821
- Published Date: Dec 20, 2024
- Report Format: PDF, PPT
- Get detailed insights on specific segments/region
- Inquire about report customization for your industry
- Learn about our special pricing for startups
- Request a demo of the report’s key findings
- Understand the report’s forecasting methodology
- Inquire about post-purchase support and updates
- Ask About Company-Level Intelligence Additions
Have specific data needs or budget constraints?
Inquiry Before BuyingFrequently Asked Questions (FAQ)
Drug Testing Equipment Market Report Scope
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Connect with our Expert
